0 Commenti
0 condivisioni
44 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Analyzing the Trastuzumab Biosimilars Market: Key Segments, Drivers, and Regional GrowthThe trastuzumab biosimilars market is shaped by a complex interplay of clinical need, regulatory environments, and regional healthcare economics. The trastuzumab biosimilars market is on a strong growth trajectory, projected to reach USD 2.5 billion by 2035. A detailed analysis of its segments and regional dynamics is essential for understanding its future direction. The market is...0 Commenti 0 condivisioni 45 Views 0 Anteprima
-
Breast Cancer Biologics: A Comprehensive Market Analysis of Trastuzumab BiosimilarsBreast cancer remains a leading cause of cancer-related deaths among women worldwide, with HER2-positive subtypes accounting for a significant portion of cases. The introduction of trastuzumab, a targeted biologic, revolutionized the treatment of this aggressive cancer. The subsequent development of breast cancer biologics in the form of trastuzumab biosimilars has expanded access to...0 Commenti 0 condivisioni 123 Views 0 Anteprima
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Commenti 0 condivisioni 1K Views 0 Anteprima
-
Global Microbial Fermentation APIs Market Growing at 1.5% CAGR Through 2032According to a new report from Intel Market Research, the global Microbial Fermentation APIs market was valued at USD 27.57 billion in 2024 and is projected to reach USD 30.56 billion by 2032, exhibiting a steady CAGR of 1.5% during the forecast period (2025–2032). This growth is driven by the increasing demand for antibiotics, amino acids, and vitamins, particularly in emerging economies...0 Commenti 0 condivisioni 1K Views 0 Anteprima